IMMUNOTHERAPY: IS IT AN AID TO CHEMOTHERAPY IN MYELOGENOUS LEUKAEMIA?Inpharma Weekly -doi:10.1007/BF03304197Springer International PublishingInpharma
Immunotherapy method described in this article only as a type of chemotherapy in the treatment method, DNA vaccines in recent years and its popularity is also different, 翻译结果4复制译文编辑译文朗读译文返回顶部 immune therapy methods described in this article only chemical therapy as a complementary...
Immunotherapy more chemotherapy safer, and faster, while the effect is consistent with the effect of chemical treatment 翻译结果4复制译文编辑译文朗读译文返回顶部 immune therapy more chemical therapy is safer and more rapid, and at the same time, its effectiveness and efficacy of a chemical treatment...
Immunotherapy or chemotherapy as local therapy of urinary bladder cancer -聽which is the most effective? Report on a meta-analysis of the long-term outcome of randomized studies comparing intravesical mitomycin C versus Bacillus Calmette-Guerin for non-muscle invasive bladder cancer. Eur Urol suppl ...
TMIC-20. UNLOCKING THE POTENTIAL OF HYPOXIA REDUCTION IN RESHAPING THE GLIOBLASTOMA TUMOR MICROENVIRONMENT FOR ENHANCED THERAPEUTIC SYNERGY reversing hypoxia-mediated immunosuppression could lead to novel combination therapies capable of overcoming resistance to both chemotherapy and immunotherapy in ... W Ivan...
the hematopoietic stem cells (HSCs) are persuaded to proliferate in an uncontrollable manner followed by the overproduction of immature WBCs [1,2]. To date, a wide variety of therapeutic strategies have been developed for AML including chemotherapy, target therapy, and immunotherapy-based treatments...
Melanoma is a highly immunogenic cancer, and has always been situated at the forefront of cancer immunotherapy development. Recent revelations into the immunotherapeutic activity of CDK4/6i, therefore, have significant implications for the utility of these agents as melanoma therapies. In recent ...
Thus, there is a clear need to identify novel treatments targeting such micrometastases. The clinical translation of strategies proposed to block this cancer cell migration has so far been discouraging8. Immunotherapy has remarkable success in some cancer types9 and different strategies have been ...
of immunotherapy and slow down tumor progression. CXCL5 and CXCR2 are also regarded as biomarkers for predicting prognosis and molecular targets for customizing the treatment. In this review, we summarized the current literature regarding the biological functions and clinical significance of CXCL5/CXCR2...
a major barrier to the development and success of immunotherapy in patients with HCC is the liver’s inherent immunosuppressive function. Recent advances in the field of cancer immunology allowed further characterization of immune cell subsets and function, and created new opportunities for therapeutic ...